Understanding human gene function in living organisms has long been hampered by fundamental differences between species.
Genetic disorders occur due to alterations in the primary genetic material—deoxyribonucleic acid (DNA)—of an organism.
CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations ...
The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...
Scientists first read the human genome, a three-billion-letter biological book, in April 2003. Since then, researchers have steadily advanced the ability to write DNA, moving far beyond single-gene ...
Scientists and physicians can better assess precision genome editing technology using a new method made public today by St. Jude Children's Research Hospital. Significant amounts of time and resources ...
Understanding human gene function in living organisms has long been hampered by fundamental differences between species. Although mice share most ...
Scientists and physicians can better assess precision genome editing technology using a new method made public today by St. Jude Children's Research Hospital. Significant amounts of time and resources ...
CHANGE-seq-BE was developed to enable scientists to better understand base editors, an important class of CRISPR precise genome editors.
The National Institutes of Health will launch a research program to encourage the development of genome-editing treatments for various diseases. Under the Somatic Cell Genome Editing program, the NIH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback